89bio, Inc. Proceeds from Stock Plans
89bio, Inc. reported Proceeds from Stock Plans of $263.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2025-08-08
- 89bio, Inc. proceeds from stock plans for the quarter ending 2024-12-31 was $178.00K, a 41.27% increase year-over-year.
- 89bio, Inc. proceeds from stock plans for the quarter ending 2024-09-30 was $0.00.
- 89bio, Inc. proceeds from stock plans for the quarter ending 2023-12-31 was $126.00K.
- 89bio, Inc. proceeds from stock plans for the quarter ending 2023-09-30 was $0.00.
- 89bio, Inc. proceeds from stock plans for fiscal 2024 was $356.00K, a 32.84% increase from fiscal 2023.
- 89bio, Inc. proceeds from stock plans for fiscal 2023 was $268.00K, a 436.00% increase from fiscal 2022.
- 89bio, Inc. proceeds from stock plans for fiscal 2022 was $50.00K.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2025-06-30 | $263.00K 10-Q · filed 2025-08-08 | |||
| 2024-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $178.00K derived: sum of 2 quarters · filed 2025-02-27 | $356.00K 10-K · filed 2025-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $178.00K 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $178.00K 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $126.00K derived: sum of 2 quarters · filed 2025-02-27 | $268.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $142.00K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $142.00K 10-Q · filed 2024-08-05 | |||
| 2022-12-31 | $50.00K 10-K · filed 2025-02-27 |